Search results
FDA approves new drug to treat Alzheimer's disease
United Press International via Yahoo Canada News· 4 days agoAlzheimer's advocates applauded the approval. "This approval marks another step forward in evolving the standard of care for people living ...
Dr. Sanjay Gupta: It’s time for President Biden to undergo detailed cognitive and neurological...
CNN.com· 1 day agoWhen the 46th President of the United States took the debate stage a week ago, it became apparent,...
'Microdosing' candies linked to illness, death, and a new Alzheimer's drug: A look at health stories...
Yahoo Life· 6 hours agoHere’s how the dog-centric mental health treatment works. Here’s other stories you need to know...
FDA approves a second Alzheimer's drug that can modestly slow disease
The Canadian Press via Yahoo Finance Canada· 4 days agoWASHINGTON (AP) — U.S. officials have approved another Alzheimer’s drug that can modestly slow the...
FDA approves new Alzheimer’s drug that slows memory decline - National | Globalnews.ca
Global B.C.· 3 days ago“This is real progress,” said Joanne Pike of the Alzheimer’s Association. Like Eisai 4523.T and Biogen’s BIIB.O rival drug Leqembi, which was approved a ...
FDA approves Alzheimer’s treatment that has been shown to slow decline in memory
AOL· 4 days agoThe Food and Drug Administration approved a new Alzheimer’s drug from Eli Lilly that has been shown in clinical trials to modestly slow a decline in memory ...
CNN's Dr. Sanjay Gupta: Biden Must Do Cognitive Testing and Release Results
The Daily Beast via Yahoo Canada News· 1 day agoSanjay Gupta called Friday for Joe Biden to undergo full neurological and cognitive testing after...
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease | CNN
CNN.com· 4 days agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to...
New Alzheimer’s Drug Donanemab Approved by FDA
Technology Networks· 3 days agoThe drug donanemab (also known as Kisunla™) has been approved by the US Food and Drug Administration (FDA) for the treatment of adults ...
New Drug Approved for Early Alzheimer’s
New York Times· 4 days agothe latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.